VENKAT REDDY: Open Payments
NPI 1720134521 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 27 payments from 11 companies in 2025. Trend: 2023 $552 · 2024 $1,259 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| Astellas Pharma US Inc | 4 | $91 |
| Indivior Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $53 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Veozah, FARXIGA, SUBLOCADE, AIRSUPRA, BREZTRI, MOUNJARO, VRAYLAR, ZEPBOUND.
Industry payments across TN — which companies pay providers there.
